ViewRay Incorporated
Oakwood Village, OH 44146
Share:
ViewRay Receives Chinese Regulatory Approval for its MRIdian System
Brings Benefits of MRI-Guided Radiation Therapy to Large and Growing Chinese Market CLEVELAND -Â- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company has received China Food and Drug Administration (CFDA) approval for its MRIdian System, the world's first and only clinical MRI-guided radiation therapy system. The MRIdian system is a unique medical instrument that integrates...
Read More »ViewRay's MRIdian System to Be Featured at Leading Medical Physics Meeting
Users to Present on Online Adaptive and Real-Time Motion Tracking with MRI-Guided Radiation Therapy CLEVELAND –Â- ViewRay®, a privately held medical device company, announced today that the company's MRIdian™ System, the world's first and only MRI-guided radiation therapy system that images and treats cancer patients simultaneously, will be featured in a broad selection of...
Read More »ViewRay to Showcase World's Only Commercially Available MRI-Guided Radiation Therapy System at Leading European Radiation Oncology Meeting
Presentations to Highlight MRIdian Clinical Implementation and its Role in On-table Adaptive Therapy CLEVELAND –Â- ViewRay™, makers of the world's first and only MRI-guided radiation therapy system, announced today that the company will showcase its MRIdian System at the 3(rd) ESTRO Forum, the annual meeting of the European Society for Radiotherapy and Oncology, being held April...
Read More »ViewRay to Showcase World's Only MRI-Guided Radiation Therapy System In Clinical Use at Largest Radiation Oncology Meeting
Doctors from Leading Cancer Center Will Discuss Firsthand Experience with MRIdian's Adaptive and Soft-Tissue Tracking Capabilities CLEVELAND - ViewRay™, a privately held medical device company, announced today that it will showcase its MRIdian™ (me-rid-i-an) system, the world's first and only MRI-guided radiation therapy system, at the 56(th) Annual Meeting of the American Society for...
Read More »ViewRay's MRIdian Makes Adaptive Radiation Therapy a Clinical Reality
World's First On-Table Adaptive Radiation Therapy Clinical Program Commenced at Siteman Cancer Center CLEVELAND, -- ViewRay(TM) Incorporated, a privately held medical device company, announced today that the world's first on-table adaptive radiation treatment program using the MRIdian(TM) (me-rid-i-an) system began at Siteman Cancer Center at Barnes-Jewish Hospital and Washington...
Read More »ViewRay to Showcase Its MRIdian System in Booth 639 at 2014 Medical Physics Meeting
MRI-Guided Radiation Therapy Selected as Hot Topic for Largest Annual Gathering of Medical Physicists CLEVELAND - ViewRay™ Incorporated, a privately held medical device company, will be featuring its MRIdian™ (me-rid-i-an) system in booth 639 at the 2014 annual meeting of the American Association of Physicists in Medicine (AAPM), which will be held July 20-24 in Austin, TX. The MRIdian system...
Read More »ViewRay Receives FDA 510(k) Clearance for MRI-Guided Radiation Therapy System
Company Reaches Significant Milestone in Development of Integrated Medical Imaging and Radiation Therapy Technology CLEVELAND - ViewRay(TM) Incorporated, a privately held medical device company, has received U.S. FDA 510(k) premarket notification clearance for its MRI-guided radiation therapy system. The ViewRay system features a unique combination of radiotherapy delivery and simultaneous...
Read More »ViewRay Partners with Leading Canadian Distributor to Bring MRI-guided Radiation Therapy to Canada
Minogue Medical to Serve as Exclusive Canadian Distributor for ViewRay's MRIdian System Cleveland, April 18, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company has partnered with Minogue Medical Inc., a leading Canadian distributor of surgical devices, operating room disposables, hospital equipment, and simulators for medical education. As part of the...
Read More »ViewRay Receives Chinese Regulatory Approval for its MRIdian System
Brings Benefits of MRI-Guided Radiation Therapy to Large and Growing Chinese Market CLEVELAND -Â- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company has received China Food and Drug Administration (CFDA) approval for its MRIdian System, the world's first and only clinical MRI-guided radiation therapy system. The MRIdian system is a unique medical instrument that integrates...
Read More »ViewRay's MRIdian System to Be Featured at Leading Medical Physics Meeting
Users to Present on Online Adaptive and Real-Time Motion Tracking with MRI-Guided Radiation Therapy CLEVELAND –Â- ViewRay®, a privately held medical device company, announced today that the company's MRIdian™ System, the world's first and only MRI-guided radiation therapy system that images and treats cancer patients simultaneously, will be featured in a broad selection of...
Read More »ViewRay to Showcase World's Only Commercially Available MRI-Guided Radiation Therapy System at Leading European Radiation Oncology Meeting
Presentations to Highlight MRIdian Clinical Implementation and its Role in On-table Adaptive Therapy CLEVELAND –Â- ViewRay™, makers of the world's first and only MRI-guided radiation therapy system, announced today that the company will showcase its MRIdian System at the 3(rd) ESTRO Forum, the annual meeting of the European Society for Radiotherapy and Oncology, being held April...
Read More »ViewRay to Showcase World's Only MRI-Guided Radiation Therapy System In Clinical Use at Largest Radiation Oncology Meeting
Doctors from Leading Cancer Center Will Discuss Firsthand Experience with MRIdian's Adaptive and Soft-Tissue Tracking Capabilities CLEVELAND - ViewRay™, a privately held medical device company, announced today that it will showcase its MRIdian™ (me-rid-i-an) system, the world's first and only MRI-guided radiation therapy system, at the 56(th) Annual Meeting of the American Society for...
Read More »ViewRay's MRIdian Makes Adaptive Radiation Therapy a Clinical Reality
World's First On-Table Adaptive Radiation Therapy Clinical Program Commenced at Siteman Cancer Center CLEVELAND, -- ViewRay(TM) Incorporated, a privately held medical device company, announced today that the world's first on-table adaptive radiation treatment program using the MRIdian(TM) (me-rid-i-an) system began at Siteman Cancer Center at Barnes-Jewish Hospital and Washington...
Read More »ViewRay to Showcase Its MRIdian System in Booth 639 at 2014 Medical Physics Meeting
MRI-Guided Radiation Therapy Selected as Hot Topic for Largest Annual Gathering of Medical Physicists CLEVELAND - ViewRay™ Incorporated, a privately held medical device company, will be featuring its MRIdian™ (me-rid-i-an) system in booth 639 at the 2014 annual meeting of the American Association of Physicists in Medicine (AAPM), which will be held July 20-24 in Austin, TX. The MRIdian system...
Read More »ViewRay Receives FDA 510(k) Clearance for MRI-Guided Radiation Therapy System
Company Reaches Significant Milestone in Development of Integrated Medical Imaging and Radiation Therapy Technology CLEVELAND - ViewRay(TM) Incorporated, a privately held medical device company, has received U.S. FDA 510(k) premarket notification clearance for its MRI-guided radiation therapy system. The ViewRay system features a unique combination of radiotherapy delivery and simultaneous...
Read More »
